Business Blog
1 minute reading time
(26 words)
Pfizer Group B strep vaccine for infants returns encouraging mid-stage trial results
Pfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands of infants each year.
Stay Informed
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.
Comments